The decision to terminate the HYPERION trial reflects a loss of clinical equipoise, making it unethical to continue the ...
A pooled analysis of results showed that progression-free survival was significantly increased in patients who received zanubrutinib compared to ibrutinib and chemo. Zanubrutinib appears to be more ...
The peripartum period is associated with an elevated risk for bleeding that can lead to the need for transfusion. A number of risk factors, including fetal and neonatal alloimmune thrombocytopenia ...
Neurologic symptoms in CLL/SLL should always prompt evaluation for CNS infiltration. Central nervous system involvement (CNSi) in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL ...
Adenoviral meningitis can be asymptomatic, and the activated lymphocytes can mimic ALL blasts, confounding the diagnosis. Distinguishing between infections and central nervous system (CNS) leukemia in ...
Local efficiency (Eloc) and global efficiency (Eglob), showed that patients with SMA had a decreased ability to integrate and transport information. Patients with spinal muscular atrophy (SMA) appear ...
Living with a rare disease has many challenges. That’s a polite way to say “it sucks!” With generalized myasthenia gravis (MG), our brains are still functioning. We may get a brain freeze moment or ...
More research is needed to determine the connection between IgG4-RD and splenic artery aneurysms. IgG4-related disease (IgG4-RD) is a disorder that can affect nearly every organ in the body and is ...
Sodium-glucose co-transporter 2 inhibitors (SGLT2is) may be associated with a more favorable prognosis in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), according to a new ...
A neonate with known HDFN was discovered to also have FNAIT after birth, necessitating immediate, intensive intervention. A 37-year-old pregnant woman (G4P2012) was known to have RhD alloimmunization.
Patients with ATTR-PN have a high rate of comorbidities and substantial direct healthcare and economic burdens, a study found.
Chronic lymphocytic leukemia (CLL) clinical features include symptoms seen at presentation, along with features seen due to lymphoid involvement, complications, and extramedullary manifestations.